Bill

Bill > HB719


PA HB719

Prohibiting discriminatory practices against applicants and enrollees under certain insurance policies based on claims or prescriptions involving prophylaxis HIV medication.


summary

Introduced
02/24/2025
In Committee
02/24/2025
Crossed Over
Passed
Dead

Introduced Session

2025-2026 Regular Session

Bill Summary

Prohibiting discriminatory practices against applicants and enrollees under certain insurance policies based on claims or prescriptions involving prophylaxis HIV medication.

AI Summary

This bill, known as the Prohibiting Insurance Discrimination for Persons on PrEP and PEP Act, aims to protect individuals from discrimination by insurers based on their use of HIV prevention medications. The bill defines key terms such as PrEP (pre-exposure prophylaxis) and PEP (post-exposure prophylaxis), which are FDA-approved medications that help prevent HIV transmission before or after potential exposure. The legislation prohibits insurers from taking adverse actions against applicants or enrollees solely because they have obtained or been prescribed these medications, including denying or canceling insurance coverage, limiting coverage, or charging different rates. Such discriminatory actions would be considered unfair discrimination under existing insurance laws and unfair insurance practices. The bill applies to various types of insurance policies, including life, disability, and long-term care policies, and will go into effect 60 days after its passage. By preventing insurers from discriminating against individuals using HIV prevention medications, the bill seeks to remove barriers to accessing these important preventive health treatments and protect individuals from potential stigma or financial penalties related to their healthcare choices.

Committee Categories

Business and Industry

Sponsors (23)

Last Action

Referred to INSURANCE (on 02/24/2025)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...